We are live on ! Find out more
ARTLW

Artelo Biosciences, Inc. Warrant
ARTLW

Delisted

ARTLW was delisted on the 17th of June, 2024.

Back to rankings

3 hedge funds and large institutions have $2.92K invested in Artelo Biosciences, Inc. Warrant in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more capital invested

Capital invested by funds: $2.76K → $2.92K (+$157)

40% less funds holding

Funds holding: 5 → 3 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
3
Holders Change
-2
Holders Change %
-40%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$48
2
Bank of America
Bank of America
North Carolina
-$7
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
1
Verition Fund Management
Connecticut
$2.21K – – –
AGM
2
Alpine Global Management
New York
$699 – – –
Morgan Stanley
3
Morgan Stanley
New York
$8 – – –
UBS Group
4
UBS Group
Switzerland
– -$48 -687 Closed
Bank of America
5
Bank of America
North Carolina
– -$7 -102 Closed

ARTLW Hedge Fund Activity: Q2 2023 in Review

3 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q2 2023, worth a combined $2.92K — up 5.7% from $2.76K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ARTLW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was UBS Group, exiting entirely with an estimated $48 sold.

  • 3 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q2 2023, down from 5 in Q1 2023.
  • Funds reported $2.92K of Artelo Biosciences, Inc. Warrant stock for Q2 2023, up 5.7% quarter-over-quarter.
  • 0 funds opened new Artelo Biosciences, Inc. Warrant positions in Q2 2023 and 2 closed out, a net change of -2 holders.
  • The largest Artelo Biosciences, Inc. Warrant seller in Q2 2023 was UBS Group, an estimated $48 sold.

Based on aggregated 13F filings for Q2 2023.